Excellio Labs Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$564K
- Investors
-
7
Excellio Labs General Information
Description
Developer of engineered exosome-based drug delivery systems designed for safe, tissue-specific therapeutic applications. The company's platform supports the development of delivery vehicles tailored for complex diseases such as cancer, neurodegeneration, cardiovascular disorders, and tissue regeneration, enabling clients with safe, efficient, and targeted drug delivery by transforming exosomes into programmable nanocarriers that overcome the limitations of conventional delivery systems.
Contact Information
Website
www.excelliolabs.comCorporate Office
- Roslin Innovation Centre
- Easter Bush Campus
- Edinburgh EH25 9RG
- Scotland, United Kingdom
Corporate Office
- Roslin Innovation Centre
- Easter Bush Campus
- Edinburgh EH25 9RG
- Scotland, United Kingdom
Excellio Labs Timeline
Excellio Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 09-Jun-2025 | $564K | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Grant | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Accelerator/Incubator | 20-Sep-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 19-Jul-2024 | Completed | Generating Revenue |
Excellio Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| A Ordinary |
Excellio Labs Signals
Excellio Labs Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Old College Capital | Venture Capital | Minority | ||
| Zinc | Venture Capital | Minority | ||
| The Bayes Centre for Entrepreneurship | Accelerator/Incubator | Minority | ||
| Cancer Tech Accelerator | Accelerator/Incubator | |||
| Innovate UK | Government |
Excellio Labs FAQs
-
When was Excellio Labs founded?
Excellio Labs was founded in 2023.
-
Where is Excellio Labs headquartered?
Excellio Labs is headquartered in Edinburgh, United Kingdom.
-
What is the size of Excellio Labs?
Excellio Labs has 4 total employees.
-
What industry is Excellio Labs in?
Excellio Labs’s primary industry is Drug Delivery.
-
Is Excellio Labs a private or public company?
Excellio Labs is a Private company.
-
What is the current valuation of Excellio Labs?
The current valuation of Excellio Labs is .
-
What is Excellio Labs’s current revenue?
The current revenue for Excellio Labs is .
-
How much funding has Excellio Labs raised over time?
Excellio Labs has raised $564K.
-
Who are Excellio Labs’s investors?
Old College Capital, Zinc, The Bayes Centre for Entrepreneurship, Cancer Tech Accelerator, and Innovate UK are 5 of 7 investors who have invested in Excellio Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process